ReviewJournal of hematology & oncology2019
MET inhibitors for targeted therapy of EGFR TKI-resistant lung cancer.
Qiming Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
160 papers cite itlatest 60 shown
this paperpooled ittrialcites it